Health Canada Approves Vera Breast CT Imaging System
The newly licensed medical device enables 3D breast imaging without the need for traditional breast compression.
Updated on Oct. 20, 2026 in Cancer

Live Poll
Should your local healthcare providers prioritize adopting new 3D breast imaging technologies?
Health Canada has granted a medical device license to Koning Health for its Vera Breast CT system. This imaging technology allows for 3D volumetric views of breast tissue without the patient discomfort typically associated with breast compression.
Why it matters
The system offers clinicians the ability to perform multi-angle examinations of breast tissue, which may improve diagnostic precision for patients. Its introduction to the commercial market represents a new option for breast imaging within Canadian healthcare centres.
The system generates 3D volumetric images of breast tissue using cone-beam CT technology. This marks the first time this specific imaging device has been licensed for use in Canada, following its previous registration in Australia.
The players
Health Canada
This federal department is responsible for helping Canadians maintain and improve their health, including the regulation of medical devices.
Koning Health
This company is the manufacturer of the Vera Breast CT system and is responsible for introducing the technology to the Canadian market.
The details
The Vera Breast CT system captures detailed volumetric images that allow clinicians to examine tissue from multiple angles. By eliminating breast compression, the technology seeks to provide a more comfortable experience for patients during their diagnostic examinations.
Timeline
Koning Health received the medical device license on October 20, 2026.
The Big Picture
The Vera Breast CT system introduction updates the diagnostic imaging options currently evaluated under the Canadian Association of Radiologists' diagnostic imaging standards. This licensing marks a departure from traditional mammography protocols by integrating non-compression volumetric scanning into the national clinical framework.
Patients may eventually see this technology implemented at local imaging centres, which could replace the discomfort of traditional breast compression with a more relaxed diagnostic experience. The exact timing for availability will depend on the installation timelines and equipment procurement at individual hospital systems.
The takeaway
The Vera Breast CT system introduces a non-compression alternative to standard diagnostic imaging, potentially improving the patient experience. Patients interested in this technology should consult their healthcare providers about the eventual local availability of these updated screening services.
Further reading
For broader context on current screening technologies, visit Canada Cancer.
Live Poll
Should your local healthcare providers prioritize adopting new 3D breast imaging technologies?









